Uterine-artery embolization versus surgery for symptomatic uterine fibroids

New England Journal of Medicine

Volumn 356, Issue 4, 2007, Pages 360-370

  Edwards, Richard D ^a   Moss, Jonathan G ^a   Lumsden, Mary Ann ^b   Wu, Olivia ^b   Murray, Lilian S ^b   Twaddle, Sara ^c   Murray, Gordon D ^d  

^a GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c Scottish Intercollegiate Guidelines Network   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE;

ADULT; AMENORRHEA; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FEVER; FOLLOW UP; HEALTH CARE COST; HOSPITALIZATION; HUMAN; HYSTERECTOMY; INFECTION; INTERMETHOD COMPARISON; MULTICENTER STUDY; MYOMECTOMY; NECROSIS; PAIN; PELVIC INFLAMMATORY DISEASE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SHORT FORM 36; SURGICAL TECHNIQUE; SYNCOPE; TREATMENT FAILURE; UTERINE ARTERY EMBOLIZATION; UTERUS MYOMA; VAGINA DISCHARGE;

EID: 33846461161     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa062003     Document Type: Article

References (24)

1. Lumsden MA, Wallace EM. Clinical presentation of uterine fibroids. Baillieres Clin Obstet Gynaecol 1998;12:177-95.
2. Edozien LC. Hysterectomy for benign conditions. BMJ 2005;330:1457-8.
3. Ravina JH, Herbreteau D, Ciraru-Vigneron N, et al. Arterial embolisation to treat uterine myomata. Lancet 1995;346:671-2.
4. Committee on Gynecologic Practice, American College of Obstetricians and Gynecologists. ACOG Committee Opinion: uterine artery embolization. Obstet Gynecol 2004;103:403-4.
5. Worthington-Kirsch R, Spies JB, Myers ER, et al. The Fibroid Registry for outcomes data (FIBROID) for uterine embolization: short-term outcomes. Obstet Gynecol 2005; 106:52-9. [Erratum, Obstet Gynecol 2005;106:869.]
6. Uterine artery embolisation for the treatment of fibroids: NICE interventional procedures guidance. Yorkshire, United Kingdom: National Institute for Health and Clinical Excellence, October 2004. (Accessed November 3, 2006, at http://www.nice.org.uk/ip020overview.)
7. Sculpher MJ, Dwyer N, Byford S, Stirrat GM. Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery. Br J Obstet Gynaecol 1996;103:142-9.
8. Jenkinson C, Peto V, Coulter A. Making sense of ambiguity: evaluation of internal reliability and face validity of the SF 36 questionnaire in women presenting with menorrhagia. Qual Health Care 1996;5:9-12.
9. Kind P. The EuroQol Instrument: an index of health related quality of life. In: Spilker B, ed. Quality of life and pharmacoeconomics in clinical trials. 2nd ed. Philadelphia: Lippincott-Raven, 1996:191-202.
10. Garry R, Fountain J, Brown J, et al. EVALUATE hysterectomy trial: a multicentre randomised trial comparing abdominal, vaginal and laparoscopic methods of hysterectomy. Health Technol Assess 2004;8:1-154.
11. Goodwin SC, Bonilla SM, Sacks D, et al. Reporting standards for uterine artery embolization for the treatment of uterine leiomyomata. J Vasc Interv Radiol 2001;12:1011-20.
12. Drummond M, Stoddart G, Torrance G. Methods for the economic evaluation of health care programmes. Oxford, England: Oxford University Press, 1987.
13. Briggs AH, Wonderling DE, Mooney CZ. Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Health Econ 1997;6:327-40.
14. Jennison C, Turnbull BW. Group sequential methods with applications to clinical trials. Boca Raton: Chapman & Hall/CRC, 2000.
15. Fletcher J, Clark MD, Sutton FA, Wellings R, Garas K. The cost of MRI: changes in costs 1989-1996. Br J Radiol 1999;72:432-7.
16. Garside R, Stein K, Wyatt K, Round A, Price A. The effectiveness and cost-effectiveness of microwave and thermal balloon endometrial ablation for heavy menstrual bleeding: a systematic review and economic modelling. Health Technol Assess 2004;8:1-155.
17. Henderson J, Bricker L, Roberts T, Mugford M, Garcia J, Neilson J. British National Health Service's and women's costs of antenatal ultrasound screening and follow-up tests. Ultrasound Obstet Gynecol 2002;20:154-62.
18. NHS National Services Scotland. Scottish Health Service costs. Edinburgh: ISD Scotland, Information Services, 2005.
19. Marret H, Keris Yle B, Acker O, Cottier JP, Herbreteau D. Late leiomyoma expulsion after uterine artery embolisation. J Vasc Interv Radiol 2004;15:1483-5.
20. Marret H, Cottier JP, Alonso AM, Giraudeau B, Body G, Herbreteau D. Predictive factors for fibroids recurrence after uterine artery embolisation. BJOG 2005;112:461-5.
21. Beinfeld MT, Bosch JL, Gazelle GS. Hospital costs of uterine artery embolization and hysterectomy for uterine fibroid tumors. Acad Radiol 2002;9:1300-4.
22. Pinto I, Chimeno P, Romo A, et al. Uterine fibroids: uterine artery embolization versus abdominal hysterectomy for treatment - a prospective, randomized, and controlled clinical trial. Radiology 2003;226:425-31.
23. Hehenkamp WJK, Volkers NA, Donderwinkel PFJ, et al. Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids (EMMY trial): peri- and postprocedural results from a randomized controlled trial. Am J Obstet Gynecol 2005;193:1618-29.
24. Zelen M. A new design for randomized clinical trials. N Engl J Med 1979;300:1242-5.